MetaCap

Crescent Biopharma Statistics

NASDAQ: CBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

13.00+0.09 (+0.70%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Crescent Biopharma by the numbers

Crescent Biopharma has a market capitalization of $543.2 million based on 38.90M shares outstanding. With trailing EPS of $-7.29, Crescent Biopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.8% below its 50-day average and 18.9% below its 200-day average.

Average daily trading volume is 361.17K shares, or about $4.7 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CBIO valuation vs. peer median

CBIO compared with the median of 8 peer companies
MetricCBIOPeer medianDifference
Market cap$543.21M$544.88M-0%
Avg. volume361.17K1.37M-74%

Peer median across 8 companies: AVBP, ACRS, CLYM, ANL, BCAX, GERN, ZVRA, ALMS.

Valuation

Market cap
$543.21M
Price / sales (latest FY)
50.09
EPS (TTM)
$-7.29

Price and trading

Previous close
12.91
Open
12.55
Day range
12.53 – 13.30
52-week range
8.72 – 27.41
52-week change
-0.46%
Beta
—
Volume
422.37K

Dividends and events

Additional statistics

Market Cap
543.21M
Forward Pe
-4.23
Eps
-7.29
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
27.41
Week52 Low
8.72
Avg Volume
361.17K
Shares Outstanding
38.90M
Ma50
14.10
Ma200
16.04
Pct From52w High
-52.57%
Pct From52w Low
49.08%

Related